Perrigo's OTC bowel drug gains FDA approval

10/7/2009 | Reuters

Perrigo received FDA approval for Polyethylene Glycol 3350, a nonprescription powder for solution to treat occasional constipation. The product is comparable to Schering-Plough HealthCare Products' MiraLAX laxative.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN